On July 22, 2022, Theator Inc. closed the transaction. The company raised $24,000,005 in the transaction. The company issued 52,519 series A-2 preferred shares for gross proceeds of $1,312,410 in its final tranche.

The transaction was led by existing investor Insight Venture Management, LLC with support from existing investors including Blumberg Capital LLC, Mayo Clinic Ventures, NFX Capital Management, LLC, StageOne Ventures, iAngels Ventures, and Neil Hunt, in addition, new growth investors including iCon Group Ltd and Ariel Cohen. The company has raised $42,500,000 in funding till date.